KEGG   PATHWAY: oro05140
Entry
oro05140                    Pathway                                
Name
Leishmaniasis - Odobenus rosmarus divergens (Pacific walrus)
Description
Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.
Class
Human Diseases; Infectious disease: parasitic
Pathway map
oro05140  Leishmaniasis
oro05140

Organism
Odobenus rosmarus divergens (Pacific walrus) [GN:oro]
Gene
101363280  TLR2; toll-like receptor 2 [KO:K10159]
101367407  uncharacterized protein LOC101367407 [KO:K10159]
101371071  TLR4; toll-like receptor 4 [KO:K10160]
101363951  MYD88; myeloid differentiation primary response protein MyD88 isoform X1 [KO:K04729]
101382179  IRAK1; interleukin-1 receptor-associated kinase 1 isoform X1 [KO:K04730] [EC:2.7.11.1]
101380365  IRAK4; interleukin-1 receptor-associated kinase 4 isoform X1 [KO:K04733] [EC:2.7.11.1]
101362953  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
101376824  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
101369401  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
101369627  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
101386560  NFKBIB; NF-kappa-B inhibitor beta isoform X2 [KO:K02581]
101384149  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
101371488  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
101381225  RELA; transcription factor p65 [KO:K04735]
101382716  IL1A; interleukin-1 alpha isoform X1 [KO:K04383]
101383005  IL1B; interleukin-1 beta [KO:K04519]
101367178  IL12A; interleukin-12 subunit alpha [KO:K05406]
101372789  IL12B; interleukin-12 subunit beta isoform X1 [KO:K05425]
101368209  TNF; tumor necrosis factor [KO:K03156]
101384443  IL4; interleukin-4 [KO:K05430]
101380967  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
101379900  IL10; interleukin-10 [KO:K05443]
101385166  TGFB1; transforming growth factor beta-1 [KO:K13375]
101380860  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
101364584  TGFB3; transforming growth factor beta-3 [KO:K13377]
101385252  C3; complement C3 [KO:K03990]
101384034  CR1L; complement component receptor 1-like protein [KO:K04011]
101374774  ITGAM; integrin alpha-M [KO:K06461]
101383612  ITGB2; integrin beta-2 [KO:K06464]
101370467  uncharacterized protein LOC101370467 [KO:K06856]
101381082  high affinity immunoglobulin gamma Fc receptor I [KO:K06498]
101363133  low affinity immunoglobulin gamma Fc region receptor III-like isoform X2 [KO:K06463]
101363662  ITGA4; integrin alpha-4 [KO:K06483]
101385291  ITGB1; integrin beta-1 isoform X1 [KO:K05719]
101375484  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
101380879  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
101376795  NCF1; neutrophil cytosol factor 1 [KO:K08011]
101385575  NCF2; neutrophil cytosol factor 2 isoform X1 [KO:K08010]
101363941  NCF4; neutrophil cytosol factor 4 [KO:K08012]
101379802  cytochrome b-245 heavy chain [KO:K21421] [EC:1.-.-.-]
101364731  cytochrome b-245 light chain [KO:K08009]
101372573  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
101382213  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
101373422  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
101366773  FOS; proto-oncogene c-Fos isoform X1 [KO:K04379]
101368207  JUN; transcription factor AP-1 isoform X1 [KO:K04448]
101377143  MAPK13; mitogen-activated protein kinase 13 isoform X1 [KO:K04441] [EC:2.7.11.24]
101377430  MAPK14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
101382259  MAPK11; mitogen-activated protein kinase 11 isoform X1 [KO:K04441] [EC:2.7.11.24]
101382558  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
101382125  IFNG; interferon gamma [KO:K04687]
101375882  IFNGR1; interferon gamma receptor 1 [KO:K05132]
101365648  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
101375007  JAK2; tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
101378785  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
101372409  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752]
101368848  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP beta 1 chain [KO:K06752]
101367969  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
101370206  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
101370503  HLA class II histocompatibility antigen, DQ beta 1 chain-like isoform X1 [KO:K06752]
101370728  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
101371503  HLA class II histocompatibility antigen, DM beta chain [KO:K06752]
101371809  HLA class II histocompatibility antigen, DO beta chain [KO:K06752]
101372107  HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
101379071  HLA class II histocompatibility antigen, DR alpha chain [KO:K06752]
101379947  H-2 class II histocompatibility antigen, E-S beta chain-like [KO:K06752]
101380246  DLA class II histocompatibility antigen, DR-1 beta chain-like [KO:K06752]
101380534  HLA class II histocompatibility antigen, DR alpha chain-like [KO:K06752]
101384348  MARCKSL1; MARCKS-related protein [KO:K13536]
101371587  elongation factor 1-alpha 1-like [KO:K03231]
101370225  elongation factor 1-alpha 1-like [KO:K03231]
101383508  EEF1A2; elongation factor 1-alpha 2 isoform X1 [KO:K03231]
101367712  elongation factor 1-alpha-like [KO:K03231]
101365854  LOW QUALITY PROTEIN: elongation factor 1-alpha 1-like [KO:K03231]
101374850  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
Compound
C00076  Calcium cation
C00195  N-Acylsphingosine
C00219  Arachidonate
C00533  Nitric oxide
C00584  Prostaglandin E2
C02737  Phosphatidylserine
Reference
  Authors
Cunningham AC
  Title
Parasitic adaptive mechanisms in infection by leishmania.
  Journal
Exp Mol Pathol 72:132-41 (2002)
DOI:10.1006/exmp.2002.2418
Reference
  Authors
Nandan D, Knutson KL, Lo R, Reiner NE
  Title
Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.
  Journal
J Leukoc Biol 67:464-70 (2000)
DOI:10.1002/jlb.67.4.464
Reference
PMID:7591091
  Authors
Nandan D, Reiner NE
  Title
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.
  Journal
Infect Immun 63:4495-500 (1995)
DOI:10.1128/IAI.63.11.4495-4500.1995
Reference
  Authors
Nandan D, Lo R, Reiner NE
  Title
Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.
  Journal
Infect Immun 67:4055-63 (1999)
DOI:10.1128/IAI.67.8.4055-4063.1999
Reference
PMID:7916951
  Authors
Reiner NE
  Title
Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.
  Journal
Immunol Today 15:374-81 (1994)
DOI:10.1016/0167-5699(94)90176-7
Reference
  Authors
Nandan D, Reiner NE
  Title
Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.
  Journal
Clin Immunol 114:266-77 (2005)
DOI:10.1016/j.clim.2004.07.017
Reference
  Authors
Kima PE
  Title
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.
  Journal
Int J Parasitol 37:1087-96 (2007)
DOI:10.1016/j.ijpara.2007.04.007
Reference
  Authors
Forget G, Gregory DJ, Olivier M
  Title
Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.
  Journal
J Biol Chem 280:30542-9 (2005)
DOI:10.1074/jbc.M414126200
Reference
  Authors
Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R
  Title
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.
  Journal
J Immunol 173:3297-304 (2004)
DOI:10.4049/jimmunol.173.5.3297
Reference
  Authors
Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V
  Title
Toll-like receptors and leishmaniasis.
  Journal
Infect Immun 76:866-72 (2008)
DOI:10.1128/IAI.01090-07
Reference
  Authors
Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I
  Title
Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.
  Journal
J Leukoc Biol 76:48-57 (2004)
DOI:10.1189/jlb.1003484
Reference
  Authors
Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY
  Title
Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.
  Journal
J Immunol 163:6403-12 (1999)
Reference
  Authors
Olivier M, Gregory DJ, Forget G
  Title
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.
  Journal
Clin Microbiol Rev 18:293-305 (2005)
DOI:10.1128/CMR.18.2.293-305.2005
Reference
  Authors
Matte C, Maion G, Mourad W, Olivier M
  Title
Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.
  Journal
Parasite Immunol 23:177-84 (2001)
DOI:10.1046/j.1365-3024.2001.00372.x
Reference
  Authors
Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S
  Title
Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.
  Journal
Infect Immun 70:6828-38 (2002)
DOI:10.1128/IAI.70.12.6828-6838.2002
Reference
PMID:9504340
  Authors
Bogdan C, Rollinghoff M
  Title
The immune response to Leishmania: mechanisms of parasite control and evasion.
  Journal
Int J Parasitol 28:121-34 (1998)
DOI:10.1016/S0020-7519(97)00169-0
Reference
  Authors
Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M
  Title
Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).
  Journal
Immunology 127:123-33 (2009)
DOI:10.1111/j.1365-2567.2008.02929.x
Reference
  Authors
Alexander J, Satoskar AR, Russell DG
  Title
Leishmania species: models of intracellular parasitism.
  Journal
J Cell Sci 112 Pt 18:2993-3002 (1999)
Reference
  Authors
Denkers EY, Butcher BA
  Title
Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
  Journal
Trends Parasitol 21:35-41 (2005)
DOI:10.1016/j.pt.2004.10.004
Reference
  Authors
Lodge R, Diallo TO, Descoteaux A
  Title
Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.
  Journal
Cell Microbiol 8:1922-31 (2006)
DOI:10.1111/j.1462-5822.2006.00758.x
Reference
  Authors
de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA
  Title
Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity.
  Journal
Curr Biol 11:1870-3 (2001)
DOI:10.1016/S0960-9822(01)00563-2
Reference
  Authors
Kane MM, Mosser DM
  Title
Leishmania parasites and their ploys to disrupt macrophage activation.
  Journal
Curr Opin Hematol 7:26-31 (2000)
DOI:10.1097/00062752-200001000-00006
Reference
  Authors
de Almeida MC, Vilhena V, Barral A, Barral-Netto M
  Title
Leishmanial infection: analysis of its first steps. A review.
  Journal
Mem Inst Oswaldo Cruz 98:861-70 (2003)
DOI:10.1590/S0074-02762003000700001
Related
pathway
oro00590  Arachidonic acid metabolism
oro04010  MAPK signaling pathway
oro04020  Calcium signaling pathway
oro04120  Ubiquitin mediated proteolysis
oro04145  Phagosome
oro04610  Complement and coagulation cascades
oro04620  Toll-like receptor signaling pathway
oro04630  JAK-STAT signaling pathway
oro04666  Fc gamma R-mediated phagocytosis
KO pathway
ko05140   
LinkDB

DBGET integrated database retrieval system